Launching Global Lung Function Initiative reference values in Belgium: tips and tricks Eric Derom, Giuseppe Liistro, Ellie Oostveen, Eric Marchand, Lieven Bedert, Rudi Peché, Wim Janssens Eur Respir J, 52 (2) 1800922; 10.1183/13993003.00922-2018 | |
Assessment of severity and prognosis in COPD: moving beyond percent of predicted Bruce H. Culver Eur Respir J, 52 (2) 1801005; 10.1183/13993003.01005-2018 | |
A clean sweep: mucin bundles clear the airway Susan Birket Eur Respir J, 52 (2) 1801144; 10.1183/13993003.01144-2018 | |
Lung function in primary ciliary dyskinesia: breaking the myth that this is a mild disease Sejal Saglani Eur Respir J, 52 (2) 1801365; 10.1183/13993003.01365-2018 | |
Radiological diagnosis of interstitial lung disease: is it all about pattern recognition? Simon L.F. Walsh, Martin Kolb Eur Respir J, 52 (2) 1801321; 10.1183/13993003.01321-2018 | |
Noninvasive ventilation for acute respiratory failure: the next step is to know when to stop Óscar Peñuelas, Andrés Esteban Eur Respir J, 52 (2) 1801185; 10.1183/13993003.01185-2018 | |
Idiopathic pulmonary fibrosis: time for greater expectations? Wim Wuyts, Vincent Cottin Eur Respir J, 52 (2) 1801312; 10.1183/13993003.01312-2018 | |
Is there a role for endothelin-1 receptor antagonists in the treatment of lung fibrosis associated with pulmonary hypertension? Jana Grune, Wolfgang M. Kuebler Eur Respir J, 52 (2) 1801287; 10.1183/13993003.01287-2018 | |
Airway smooth muscle may drive mucus hypersecretion in asthma James G. Martin Eur Respir J, 52 (2) 1801166; 10.1183/13993003.01166-2018 | |
Death to the neutrophil! A resolution for acute respiratory distress syndrome? Brittney N.V. Scott, Paul Kubes Eur Respir J, 52 (2) 1801274; 10.1183/13993003.01274-2018 | |
Lung function in patients with primary ciliary dyskinesia: an iPCD Cohort study Florian S. Halbeisen, Myrofora Goutaki, Ben D. Spycher, Israel Amirav, Laura Behan, Mieke Boon, Claire Hogg, Carmen Casaulta, Suzanne Crowley, Eric G. Haarman, Bulent Karadag, Cordula Koerner-Rettberg, Michael R. Loebinger, Henryk Mazurek, Lucy Morgan, Kim G. Nielsen, Heymut Omran, Francesca Santamaria, Nicolaus Schwerk, Guillaume Thouvenin, Panayiotis Yiallouros, Jane S. Lucas, Philipp Latzin, Claudia E. Kuehni Eur Respir J, 52 (2) 1801040; 10.1183/13993003.01040-2018 | |
Role of C1q-binding anti-HLA antibodies as a predictor of lung allograft outcome Olivier Brugière, Antoine Roux, Jerome Le Pavec, Deborah Sroussi, François Parquin, Pauline Pradère, Clairelyne Dupin, Vincent Bunel, Gisele Mourin, Gilles Jebrak, Gaëlle Dauriat, Yves Castier, Pierre Mordant, Brice Lortat-Jacob, Sylvain Jean-Baptiste, Herve Mal, Caroline Suberbielle, Chantal Gautreau, Sophie Caillat-Zucman, Aurélie Cazes, Gabriel Thabut, Jean-Luc Taupin Eur Respir J, 52 (2) 1701898; 10.1183/13993003.01898-2017 | |
Familial aggregation and heritability of sarcoidosis: a Swedish nested case-control study Marios Rossides, Johan Grunewald, Anders Eklund, Susanna Kullberg, Daniela Di Giuseppe, Johan Askling, Elizabeth V. Arkema Eur Respir J, 52 (2) 1800385; 10.1183/13993003.00385-2018 | |
Safety of nintedanib added to pirfenidone treatment for idiopathic pulmonary fibrosis Kevin R. Flaherty, Charlene D. Fell, J. Terrill Huggins, Hilario Nunes, Robert Sussman, Claudia Valenzuela, Ute Petzinger, John L. Stauffer, Frank Gilberg, Monica Bengus, Marlies Wijsenbeek Eur Respir J, 52 (2) 1800230; 10.1183/13993003.00230-2018 | |
Stability or improvement in forced vital capacity with nintedanib in patients with idiopathic pulmonary fibrosis Kevin R. Flaherty, Martin Kolb, Carlo Vancheri, Wenbo Tang, Craig S. Conoscenti, Luca Richeldi Eur Respir J, 52 (2) 1702593; 10.1183/13993003.02593-2017 | |
Profiling of healthy and asthmatic airway smooth muscle cells following interleukin-1ß treatment: a novel role for CCL20 in chronic mucus hypersecretion Alen Faiz, Markus Weckmann, Haitatip Tasena, Corneel J. Vermeulen, Maarten Van den Berge, Nick H.T. ten Hacken, Andrew J. Halayko, Jeremy P.T. Ward, Tak H. Lee, Gavin Tjin, Judith L. Black, Mehra Haghi, Cheng-Jian Xu, Gregory G. King, Claude S. Farah, Brian G. Oliver, Irene H. Heijink, Janette K. Burgess Eur Respir J, 52 (2) 1800310; 10.1183/13993003.00310-2018 | |
Impaired efferocytosis and neutrophil extracellular trap clearance by macrophages in ARDS Murielle Grégoire, Fabrice Uhel, Mathieu Lesouhaitier, Arnaud Gacouin, Marion Guirriec, Frederic Mourcin, Erwan Dumontet, Arnaud Chalin, Michel Samson, Laure-Line Berthelot, Adrien Tissot, Mallorie Kerjouan, Stéphane Jouneau, Yves Le Tulzo, Karin Tarte, Jaroslaw W. Zmijewski, Jean-Marc Tadié Eur Respir J, 52 (2) 1702590; 10.1183/13993003.02590-2017 | |
Maternal adiposity in pregnancy and offspring asthma in adulthood Anna P. Westberg, Minna K. Salonen, Mikaela von Bonsdorff, Clive Osmond, Eero Kajantie, Johan G. Eriksson Eur Respir J, 52 (2) 1801152; 10.1183/13993003.01152-2018 | |
Lung function trajectories using different reference equations in a birth cohort study up to the age of 20 years Christiane Lex, Marvin Reuter, Antje Schuster, Linus Grabenhenrich, Carl-Peter Bauer, Ute Hoffmann, Johannes Forster, Fred Zepp, Ulrich Wahn, Thomas Keil, Susanne Lau, Dirk Schramm Eur Respir J, 52 (2) 1800364; 10.1183/13993003.00364-2018 | |
QT prolongation and cardiac toxicity of new tuberculosis drugs in Europe: a Tuberculosis Network European Trialsgroup (TBnet) study Lorenzo Guglielmetti, Simon Tiberi, Matthew Burman, Heinke Kunst, Christian Wejse, Tamar Togonidze, Graham Bothamley, Christoph Lange Eur Respir J, 52 (2) 1800537; 10.1183/13993003.00537-2018 | |
Nonadherence with inhaled preventer therapy in severe asthmatic patients on long-term omalizumab David J. Allen, Leanne-Jo Holmes, Kerry A. Hince, Rachael Daly, Calra Ustabashi, Gael Tavernier Eur Respir J, 52 (2) 1801025; 10.1183/13993003.01025-2018 | |
Impact of turnaround time on outcome with point-of-care testing for respiratory viruses: a post hoc analysis from a randomised controlled trial Nathan J. Brendish, Ahalya K. Malachira, Kate R. Beard, Sean Ewings, Tristan W. Clark Eur Respir J, 52 (2) 1800555; 10.1183/13993003.00555-2018 | |
Rhinovirus is the most common virus and rhinovirus-C is the most common species in paediatric intensive care respiratory admissions Desmond W. Cox, Siew-Kim Khoo, Guicheng Zhang, Katie Lindsay, Anthony D. Keil, Geoff Knight, James E. Gern, Ingrid A. Laing, Joelene Bizzintino, Peter N. Le Souëf Eur Respir J, 52 (2) 1800207; 10.1183/13993003.00207-2018 | |
Nitrogen multiple breath washout test for infants with cystic fibrosis Václav Koucký, Veronika Skalická, Petr Pohunek Eur Respir J, 52 (2) 1800015; 10.1183/13993003.00015-2018 | |
Should reversibility be assessed in all asthmatic children with normal spirometry? Edouard Dufetelle, Plamen Bokov, Christophe Delclaux, Nicole Beydon Eur Respir J, 52 (2) 1800373; 10.1183/13993003.00373-2018 | |